Moy-Fincher Medical Group has received a warning letter form the Food and Drug Administration (FDA) following a review of its web site, www.dnaegfrenewal.com in December 2014. The product in question is DNA Eye Renewal, “appears to be promoted for conditions that cause the product to be drugs under section 201(g)(l)(C) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(C)],” according to FDA’s letter, which was mailed in February. According to the FDA document, examp...